Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline, Budesonide, and Antibiotics in Post-Op Endoscopic Sinus Surgery
NCT03303677Phase 3
Key facts
- Status
- Withdrawn
- Start
- Apr 2018
- Primary completion
- Nov 2018
- Countries
- 1
- Sponsor
- University of Florida
- Modality
- Orthosteric Ligands
- Drugs
- budesonide
- Conditions
- chronic rhinosinusitis (CRS)
01
Overview
Phase 3, randomised, open-label trial of budesonide in chronic rhinosinusitis (CRS), sponsored by University of Florida. Planned start Apr 2018; status: withdrawn.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Adults with chronic rhinosinusitis undergoing endoscopic sinus surgery.
04
Registry description
The goal of the study is to compare postoperative symptom scores and endoscopy findings between in patients who receive either nasal saline rinses, saline + budesonide, and saline + topical antibiotics and budesonide following endoscopic sinus surgery.
Beyond the preview
Go deeper on NCT03303677.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03303677.